Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
January 24, 2008

Clinical Data and Affymetrix Sign  Marketing Deal for New Drug Metabolism Service

  • Clinical Data and Affymetrix signed a marketing agreement for Affymetrix’ drug metabolizing enzymes and transporter (DMET) early access solution. Cogenics and Epidauros Biotechnologie, both subsidiaries of Clinical Data, will offer the DMET services on a global basis, with limited exclusivity in Europe.

    The DMET early access solution provides a method for assaying the genetics of drug metabolism, according to Affymetrix.

Related content

  • Finally! A cure for the Biotech News Blues.

  • Join 110,000 colleagues who rely on GEN Highlights for breaking news and exclusive articles shaping today’s life science tools and technologies.

  • Oops! Please type your email in the following format: yourname@example.com An error has occurred. Please contact Customer Service at contactGEN@genengnews.com
  • You’re all set! Thank you for subscribing to GEN Highlights.